Cargando…

Accelerated Cardiac Aging in Patients With Congenital Heart Disease

An increasing number of patients with congenital heart disease (CHD) survive into adulthood but develop long-term complications including heart failure (HF). Cellular senescence, classically defined as stable cell cycle arrest, is implicated in biological processes such as embryogenesis, wound heali...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacobazzi, Dominga, Alvino, Valeria Vincenza, Caputo, Massimo, Madeddu, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177956/
https://www.ncbi.nlm.nih.gov/pubmed/35694664
http://dx.doi.org/10.3389/fcvm.2022.892861
_version_ 1784722951490240512
author Iacobazzi, Dominga
Alvino, Valeria Vincenza
Caputo, Massimo
Madeddu, Paolo
author_facet Iacobazzi, Dominga
Alvino, Valeria Vincenza
Caputo, Massimo
Madeddu, Paolo
author_sort Iacobazzi, Dominga
collection PubMed
description An increasing number of patients with congenital heart disease (CHD) survive into adulthood but develop long-term complications including heart failure (HF). Cellular senescence, classically defined as stable cell cycle arrest, is implicated in biological processes such as embryogenesis, wound healing, and aging. Senescent cells have a complex senescence-associated secretory phenotype (SASP), involving a range of pro-inflammatory factors with important paracrine and autocrine effects on cell and tissue biology. While senescence has been mainly considered as a cause of diseases in the adulthood, it may be also implicated in some of the poor outcomes seen in patients with complex CHD. We propose that patients with CHD suffer from multiple repeated stress from an early stage of the life, which wear out homeostatic mechanisms and cause premature cardiac aging, with this term referring to the time-related irreversible deterioration of the organ physiological functions and integrity. In this review article, we gathered evidence from the literature indicating that growing up with CHD leads to abnormal inflammatory response, loss of proteostasis, and precocious age in cardiac cells. Novel research on this topic may inspire new therapies preventing HF in adult CHD patients.
format Online
Article
Text
id pubmed-9177956
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91779562022-06-10 Accelerated Cardiac Aging in Patients With Congenital Heart Disease Iacobazzi, Dominga Alvino, Valeria Vincenza Caputo, Massimo Madeddu, Paolo Front Cardiovasc Med Cardiovascular Medicine An increasing number of patients with congenital heart disease (CHD) survive into adulthood but develop long-term complications including heart failure (HF). Cellular senescence, classically defined as stable cell cycle arrest, is implicated in biological processes such as embryogenesis, wound healing, and aging. Senescent cells have a complex senescence-associated secretory phenotype (SASP), involving a range of pro-inflammatory factors with important paracrine and autocrine effects on cell and tissue biology. While senescence has been mainly considered as a cause of diseases in the adulthood, it may be also implicated in some of the poor outcomes seen in patients with complex CHD. We propose that patients with CHD suffer from multiple repeated stress from an early stage of the life, which wear out homeostatic mechanisms and cause premature cardiac aging, with this term referring to the time-related irreversible deterioration of the organ physiological functions and integrity. In this review article, we gathered evidence from the literature indicating that growing up with CHD leads to abnormal inflammatory response, loss of proteostasis, and precocious age in cardiac cells. Novel research on this topic may inspire new therapies preventing HF in adult CHD patients. Frontiers Media S.A. 2022-05-26 /pmc/articles/PMC9177956/ /pubmed/35694664 http://dx.doi.org/10.3389/fcvm.2022.892861 Text en Copyright © 2022 Iacobazzi, Alvino, Caputo and Madeddu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Iacobazzi, Dominga
Alvino, Valeria Vincenza
Caputo, Massimo
Madeddu, Paolo
Accelerated Cardiac Aging in Patients With Congenital Heart Disease
title Accelerated Cardiac Aging in Patients With Congenital Heart Disease
title_full Accelerated Cardiac Aging in Patients With Congenital Heart Disease
title_fullStr Accelerated Cardiac Aging in Patients With Congenital Heart Disease
title_full_unstemmed Accelerated Cardiac Aging in Patients With Congenital Heart Disease
title_short Accelerated Cardiac Aging in Patients With Congenital Heart Disease
title_sort accelerated cardiac aging in patients with congenital heart disease
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177956/
https://www.ncbi.nlm.nih.gov/pubmed/35694664
http://dx.doi.org/10.3389/fcvm.2022.892861
work_keys_str_mv AT iacobazzidominga acceleratedcardiacaginginpatientswithcongenitalheartdisease
AT alvinovaleriavincenza acceleratedcardiacaginginpatientswithcongenitalheartdisease
AT caputomassimo acceleratedcardiacaginginpatientswithcongenitalheartdisease
AT madeddupaolo acceleratedcardiacaginginpatientswithcongenitalheartdisease